Get started
Author

Steven A. Kemp

Observed names: Kemp, Steven, Kemp, Steven A, Kemp, Steven A., SA Kemp (16723710), Stephen A. Kemp, Steve Kemp, Steven A Kemp, Steven A Kemp (16293413), Steven Kemp
Observed institutions: University of Liverpool, University of Cape Town, University of Cambridge, University of Oxford, Institute of Infectious Disease and Molecular Medicine, University College London
ORCID: 0000-0001-7077-6793
Observed ORCID: 0000-0001-7077-6793
OpenAlex ID: A5071338183
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
2021 · Petra Mlcochova, Steven A. Kemp, et al. · Nature · 1,331
PDF
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
2022 · Bo Meng, Adam Abdullahi, et al. · Nature · 1,142
PDF
SARS-CoV-2 evolution during treatment of chronic infection
2021 · Steven A. Kemp, Dami A. Collier, et al. · Nature · 1,093
PDF
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
2021 · Dami A. Collier, Anna De Marco, et al. · Nature · 729
PDF
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
2021 · Bo Meng, Steven A. Kemp, et al. · Cell Reports · 407
PDF
Recurrent Emergence and Transmission of a SARS-CoV-2 Spike Deletion H69/V70
2020 · Steven A Kemp, Bo Meng, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 253
PDF
Prevalence of persistent SARS-CoV-2 in a large community surveillance study
2024 · Mahan Ghafari, Matthew Hall, et al. · Nature · 153
PDF
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion
2021 · Isabella A T M Ferreira, Steven A Kemp, et al. · The Journal of Infectious Diseases · 151
PDF
SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough
2021 · Petra Mlcochova, Steven Kemp, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 90
PDF
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
2020 · Mark J. Siedner, Michelle A. Moorhouse, et al. · Nature Communications · 81
PDF
A Cross-Sectional Survey of the Knowledge, Attitudes, and Practices of Antimicrobial Users and Providers in an Area of High-Density Livestock-Human Population in Western Kenya
2021 · Steven A. Kemp, Gina L. Pinchbeck, et al. · Frontiers in Veterinary Science · 49
SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies
2021 · Petra Mlčochová, Steven A. Kemp, et al. · Greater South Information System · 36
SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa
2022 · Adam Abdullahi, David Oladele, et al. · Nature Communications · 33
PDF
Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly
2023 · Isabella A.T.M. Ferreira, Colin Y.C. Lee, et al. · Cell Reports · 30
PDF
Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohort
2023 · Adam Abdullahi, Ibrahim Musa Kida, et al. · Journal of Antimicrobial Chemotherapy · 27
PDF
High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatment
2020 · Kate El Bouzidi, Steven A Kemp, et al. · Journal of Antimicrobial Chemotherapy · 19
PDF
HIV transmission dynamics and population-wide drug resistance in rural South Africa
2024 · Steven A. Kemp, Kimia Kamelian, et al. · Nature Communications · 18
SARS-CoV-2 genomic diversity and within-host evolution in individuals with persistent infection in the UK: an observational, longitudinal, population-based surveillance study
2025 · Mahan Ghafari, Steven A. Kemp, et al. · The Lancet Microbe · 14
In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix
2020 · Rawlings Datir, Steven Kemp, et al. · mBio · 13
Transmission of B.1.617.2 Delta variant between vaccinated healthcare workers
2022 · Steven A. Kemp, Mark T. K. Cheng, et al. · Scientific Reports · 12
PDF
HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy
2022 · Steven A. Kemp, Oscar J. Charles, et al. · mBio · 12
Recurrent independent emergence and transmission of SARS-CoV-2 Spike amino acid H69/V70 deletions
2021 · Ravindra Gupta, Steven Kemp, et al. · Research Square · 11
PDF
Signatures of omicron-like adaptation in early SARS-CoV-2 variants and chronic infection
2025 · Mark Tsz Kin Cheng, Mazharul Altaf, et al. · Cell Reports · 9
PDF
Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppression
2025 · Kimia Kamelian, Benjamin Sievers, et al. · Science Advances · 8
PDF
Author Correction: SARS-CoV-2 evolution during treatment of chronic infection
2022 · Steven A. Kemp, Dami A. Collier, et al. · Nature · 5
PDF
Works count: 61
Citation count: 5,779
H-index: 18
I10-index: 23
Year
Topic
Type